MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: Correlation with clinical outcomes

Laryngoscope

Volumn 114, Issue 8 II, 2004, Pages 1-32

  Weed, Donald T ^a   Gomez Fernandez, Carmen ^a   Yasin, Mohammed ^a   Hamilton Nelson, Kara ^a   Rodriguez, Michael ^a   Zhang, Jin ^a   Carraway, Kermit L ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

ErbB2; MUC4; Prognosis; Squamous carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MUCIN; MUCIN 4; POLYCLONAL ANTIBODY; SIALOMUCIN;

ADULT; AGED; ANTIGEN EXPRESSION; CANCER RECURRENCE; CANCER SURVIVAL; CELL INTERACTION; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

EID: 3843074350     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200408001-00001     Document Type: Review

References (46)

1. Nollet S, Moniaux N, Maury J, et al. Human mucin gene MUC4: organization of its 5′-region and polymorphism of its central tandem repeat array. Biochem J 1998;332: 739-748.
2. Moniaux N, Nollet S, Porchet, Degand P, Laine A, Aubert J-P. Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 1999;338: 325-333.
3. Carraway KL, Price-Schiavi SA, Komatsu M, Jepson S, Perez A, Carraway CAC. Muc4/sialomucin complex in the mammary gland and breast Cancer J Mammary Gland Biol Neoplasia 2001;6:323-337.
4. McNeer RR, Price-Schiavi SP, Komatsu M, Fregien N, Carraway CAC, Carraway KL. Sialomucin complex in tumors and tissues. Front Bioscience 1997;2:D449-D459.
5. Komatsu M, Carraway CAC, Fregein NL, Carraway KL. Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J Biol Chem 1997;272:33245-33254.
6. Carraway KL III, Rossi EA, Komatsu M, et al. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J Biol Chem 1999; 274:5263-5266.
7. Sheng Z, Wu K, Carraway KL, Freigien N. Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex: a new member of the epidermal growth factor superfamily. J Biol Chem 1992; 267:16341-16346.
8. Choudhury A, Moniaux N, Winpenny JP, Hollingsworth MA, Aubert JP, Batra SK. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem 2000;128: 233-243.
9. Choudhury A, Moniaux N, Ringel J, et al. Alternate splicing at the 3′-end of the human pancreatic tumor-associated mucin MUC4 cDNA. Teratog Carcinog Mutagen 2001;21: 83-96.
10. Carraway KL, Ramsauer VP, Haq B, Carraway CAC. Cell signaling through membrane mucins. Bioessays 2003;25: 66-71.
11. kip, but does not activate mitogen-activated kinase or protein kinase B/Akt pathways. Oncogene 2002;24: 7524-7532.
12. Carraway KL, Price-Schiavi SA, Komatsu M, et al. Multiple facets of sialomucin complex/MUC4, a membrane mucin and ErbB2 Ligand, in Tumors and Tissues (Y2K Update). Front Biosci 2000;5:D95-D107.
13. Weed DT, Gomez-Fernandez C, Bonfante E, et al. MUC4 (sialomucin complex) expression in salivary gland tumors and squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:127-141.
14. Idris N, Carraway KL. Sialomucin complex (Muc4) expression in the rat female reproductive tract. Biol Reprod 1999; 61:1431-1438.
15. Price-Schiavi SA, Meller D, Jing X, et al. Sialomucin complex at the rat ocular surface: a new model for ocular surface protection. Biochem J 1998;335:457-463.
16. Guillem P, Billeret V, Buisine MP, et al. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 2000;88: 856-861.
17. Carraway KL, Perez A, Idris N, et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and survive. Prog Nucleic Acids Res Mol Biol 2001;171:149-185.
18. Lopez-Ferrer A, Curull V, Barranco C, et al. Mucins as differentiation markers in bronchial epithelium: squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 2001;24:22-29.
19. Reid CJ, Harris A. Developmental expression of mucin genes in the human gastrointestinal system. Gut 1998;42: 220-226.
20. Buisine MP, Devisme L, Copin MC, et al. Developmental mucin gene expression in the human respiratory tract. Am J Respir Cell Mol Biol 1999;20:209-218.
21. Buisine MP, Devisme L, Maunoury V, et al. Developmental expression in the gastroduodenal tract and accessory digestive glands, I: stomach-a relationship to gastric carcinoma. J Histochem Cytochem 2000;48:1657-1666.
22. Lopez-Ferrer A, de Bolos C, Barranco C, et al. Role of fucosyltrasnferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut 2000;47:349-356.
23. Buisine MP, Devisme L, Degand P, et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands, II: Duodenum and Liver, Gallbladder, and Pancreas. J Histochem Cytochem 2000;48: 1667-1676.
24. Reid CJ, Gould S, Harris A. Developmental expression of mucin genes in the human respiratory tract. Am J Respir Cell Mol Biol 1997;17:592-598.
25. Giuntoli RL II, Rodriguez GC, Whitaker RS, Dodge R, Voynow JA. Mucin gene expression in ovarian cancers. Cancer Res 1998;58:5546-5550.
26. Weed DT, Gomez-Fernandez C, Pacheco J, et al. MUC4 and ErbB2 expression in major and minor salivary gland mucoepidermoid carcinoma. Head Neck 2004;26:353-364.
27. Komatsu M, Yee L, Carraway KL. Overexpression of sialomucin complex, a rat homolog of MUC4, inhibits tumor killing by lymphokine-activated killer cells. Cancer Res 1999;59:2229-2236.
28. Wu K, Salas PJ, Yee L, Fregien N, Carraway KL. Tissue and tumor expression of a cell surface glycoprotein complex containing an integral membrane glycoprotein activator of p185neu. Oncogene 1994;9:3139-3147.
29. Price-Schiavi SA, Jepson S, Li P, et al. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for Herceptin resistance. Int J Cancer 2002;99:783-791.
30. Lopez-Ferrer A, Alameda F, Barranco C, Garrido M, de Bolos C. MUC4 expression is increased in dysplastic cervical disorders. Hum Pathol 2001;32:1197-1202.
31. Lee KT, Liu TS. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas. Dig Dis Sci 2001;46:2166-2172.
32. Hanaoka J, Kontani K, Sawai S, et al. Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity. Cancer 2001;92:2148-2157.
33. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogen amplifications in head neck squamous cell carcinoma. Cancer Res 2003;63:1179-1182.
34. Craven JM, Pavelic ZP, Stambrook PJ, et al. Expression of c-erbB2 gene in human head neck carcinoma. Anticancer Res 1992;12:2273-2276.
35. Werkmeister R, Brandt B, Joos U. The erbB oncogens as prognostic markers in oral squamous cell carcinomas. Am J Surg 1996;172:681-683.
36. Xia W, Lau Y-K, Zhang H-Z, et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 1999;5:4164-4174.
37. Xia W, Lau Y-KL, Zhang HZ, et al. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 1997;3:3-9.
38. Rutland PS, Hughes CM. Immunocytochemical identification of cell types in human mammary gland: variations in cellular markers are dependent on glandular topography and differentiation. J Histochem Cytochem 1989;37:1087-1100.
39. Hull SR, Sheng Z, Vanderpuye O, David C, Carraway KL. Isolation and partial characterization of ascites sialoglycoprotein-2 (ASGP-2) of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells. Biochem J 1990;265:121-129.
40. Cachin. Perspectives on cancer of the head neck. In: Myers EN, Suen JY, ed. Cancer of the Head Neck, 2nd ed. New York: Churchill Livingstone; 1989:1-16.
41. Greenberg JS, Fowler R, Gomez J, et al. Extent of extracapsular spread: a critical prognostic factor in oral tongue cancer. Cancer 2003;97:1464-1470.
42. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma: implication for therapeutic decision making. Cancer 2003;98:508-515.
43. Myers HJN, Greenberg JS, Roberts D. Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001;92: 3030-3036.
44. Cooper JS, Pajak TF, Forastiere A, et al. Precisely defining high-risk operable head neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck 1998;20:588-594.
45. Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head neck. Arch Otolaryngol Head Neck Surg 1998; 124:637-640.
46. Fukano H, Matsura H, Hasegawa Y, Nakamura S. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997;19: 205-210.